Hauptinhalt

Originalarbeiten und Reviews 2022

Originalarbeiten 2022:

  1. Prevalence of SARS-CoV-2 antibodies in hospital employees, central Germany.
    Keller C, Chung H, Jerrentrup A, Janßen B, Fritsch HW, Feldmann L, Dreute J, Wölfel F, Günther S, Renz H.
    J Lab Med, 46(1):61-69, 2022
    doi: doi.org/10.1515/labmed-2021-0107
    (IF 0.4)
  2. Treatment of Femoral Head Osteonecrosis with Ozone Therapy: Pilot Trial of a New Therapeutic Approach.
    An JX, Wu GP, Niu K, Wie YP, Liu H, Gao XY, Wu JP, Wang Y, Renz H, Williams JP.
    Pain Physician 25:E43-E54, 2022
    doi: (keine) PMID: 35051151
    (IF 4.4)
  3. Immune Responsiveness to LPS Determines Risk of Childhood Wheeze and Asthma in 17q21 Risk Allele Carriers.
    Illi S, Depner M, Pfefferle PI, Renz H, Roduit C, Taft DH, Kalanetra KM, Mills DA, Farquharson FM, Louis P, Schmausser-Hechfellner E, Divaret-Chauveau A, Lauener R, Karvonen AM, Pekkanen J, Kirjavainen PV, Roponen M, Riedler J, Kabesch M, Schaub B, von Mutius E; PASTURE Study Group.
    Am J Respir Crit Care Med. 205(6):641-650, 2022
    doi: 10.1164/rccm.202106-1458OC
    (IF 21.4)
  4. Novel imaging phenotypes of naïve asthma patients with distinctive clinical characteristics and T2 inflammation traits.
    Yang Z, Qin L, Qiao J, Cheng C, Liu Y, Zhang S, Fang X, Li Z, Renz H, Liu X, Xia L, Hu Q, Xie M.
    Ther Adv Chronic Dis. 13:20406223221084831, 2022
    doi: 10.1177/20406223221084831.
    (IF 4.9)

  5. Short-Chain Fatty Acids Augment Differentiation and Function of Human Induced Regulatory T Cells.
    Hu M, Alashkar Alhamwe B, Santner-Nanan B, Miethe S, Harb H, Renz H, Potaczek DP, Nanan RK.
    Int J Mol Sci. 23(10):5740, 2022
    doi: 10.3390/ijms23105740
    (IF 6.2)
  6. COVID-19 remote early detection (COVID-RED) consortium. Investigation of the use of a sensor bracelet for the presymptomatic detection of changes in physiological parameters related to COVID-19: an interim analysis of a prospective cohort study (COVI-GAPP).
    Risch M, Grossmann K, Aeschbacher S, Weideli OC, Kovac M, Pereira F, Wohlwend N, Risch C, Hillmann D, Lung T, Renz H, Twerenbold R, Rothenbühler M, Leibovitz D, Kovacevic V, Markovic A, Klaver P, Brakenhoff TB, Franks B, Mitratza M, Downward GS, Dowling A, Montes S, Grobbee DE, Cronin M, Conen D, Goodale BM, Risch L;
    BMJ Open 12(6):e058274, 2022
    doi: 10.1136/bmjopen-2021-058274.
    (IF 3.0)
  7. Respiratory viral co‐infections in patients with COVID‐19 and associated outcomes: A systematic review and metaanalysis.
    Krumbein H, Kümmel LS, Paraskevi CF, Thölken C, Hünerbein BL, Reiter R, Papathanasiou KA, Renz H, Skevaki C.
    Rev Med Virol. e2365, 2022 (Online ahead of print)
    doi: 10.1002/rmv.2365
    (IF 11.0)
  8. T-high asthma phenotypes across life span.
    Maison N, Omony J, Illi S, Thiele D, Skevaki C, Dittrich AM, Bahmer T, Rabe KF, Weckmann M, Happle C, Schaub B, Meier M, Foth S, Rietschel E, Renz H, Hansen G, Kopp MV, von Mutius E, Grychtol R; ALLIANCE Study Group.
    Eur Respir J. 2102288, 2022
    doi: 10.1183/13993003.02288-2021 (online ahead of print)
    (IF 16.7)
  9. Autoantibodies targeting cytokines and connective tissue disease autoantigens are common in acute non-SARS-CoV-2 infections.
    J, Mao R, Pinedo K, Roque J, Richards C, Stabile M, Swaminathan G, Salagianni M, Triantafyllia V, Bertrams W, Blish C, Carette J, Frankovich J, Meffre E, Nadeau KC, Singh U, Wang T, Prak EL, Herold S, Andreakos E, Schmeck B, Skevaki C, Rogers A, Utz P.
    Res Sq. rs.3.rs-1233038, 2022 (Preprint)
    doi: 10.21203/rs.3.rs-1233038/v1
  10. Pharmacological modulation of myeloid derived suppressor cells to dampen inflammation.
    van Geffen C, Heiss C, Deißler A, Kolahian S.
    Front. Immunol. 13:933847, 2022
    doi: 10.3389/fimmu.2022.933847
    (IF 8.786)